" class="no-js "lang="en-US"> Chris Chaney - Medtech Alert
  • Home
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions
Saturday, July 19, 2025

Light/Dark

  • News
    • Artificial Intelligence
    • Clinical Trials
    • Drug Development
    • Equipment
    • Gene Therapy
    • Health Apps
    • Manufacturing
    • Regulatory
    • Smart Labs
    • Supply Chain
  • Medtech TV
  • Industry News
    • Appointments
    • Fundraising
    • Mergers & Aquisitions
    • Partnerships
  • Diseases
    • Cardiovascular
    • COVID-19
    • Immunology
    • Infectious Diseases
    • Oncology
    • Respiratory
  • Resources
    • Companies
    • People
    • White Papers
  • News
    • Artificial Intelligence
    • Clinical Trials
    • Drug Development
    • Equipment
    • Gene Therapy
    • Health Apps
    • Manufacturing
    • Regulatory
    • Smart Labs
    • Supply Chain
  • Medtech TV
  • Industry News
    • Appointments
    • Fundraising
    • Mergers & Aquisitions
    • Partnerships
  • Diseases
    • Cardiovascular
    • COVID-19
    • Immunology
    • Infectious Diseases
    • Oncology
    • Respiratory
  • Resources
    • Companies
    • People
    • White Papers

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors

Home » People » Chris Chaney

Chris Chaney

Chris Chaney

About Chris Chaney

Chris joined CW+ as Chief Executive in July 2016 and leads the charity to raise funds to provide new facilities, deliver our unique arts and health programme, and identify and embed next generation systems and technologies to support patients and staff. In addition to his charity role, Chris is strategic communications lead at the Trust and sits as a member of the Trust board.

Prior to CW+, Chris was Head of Major Gifts at the University of Cambridge and spent over ten years at Great Ormond Street Hospital Children’s Charity. Chris is currently a Trustee of Newlife – The Charity for Disabled Children and sits on grants committees at the True Colours Trust and the National Institute for Health Research.

Related Story

Cardiovascular

Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care | Pharmtech Focus

Novartis Pharmaceuticals UK Launches World-first Health-tech Investor Partnership to Reimagine Cardiovascular Care

July 6 2022

Novartis Pharmaceuticals UK announces the launch of the Novartis Biome UK Heart Health Catalyst 2022, […]

Join Our Newsletter.

Subscribe to receive email updates from Medtech Alert.

By signing up, I agree to receive emails from Medtech Alert and to the Privacy Policy and Terms of Use.

Copyright © 2022 Advertainment Media All Rights Reserved.

Medtech Alert report on the latest Medical and Pharmaceutical technology news, bringing you up to the minute stories and features to stay ahead. Industry professionals and decision makers turn to us to keep up with and shape their industry.

For Media, Press and Advertising Enquiries please use our contact form or email address:


Contact

Email

Advertainment Media Ltd.
Pantiles Chambers
85 High Street
Tunbridge Wells
TN1 1XP

  • Home
  • Privacy Policy
  • Cookie Policy
  • Terms & Conditions